Skip to main content

Platform E – Surgery

Monday, December 6, 2021
-

You may need to log in to view video on this page.

There will be two concurrent sessions of selected key scientific abstracts. Authors will present a 10-minute overview of their work followed by a five-minute Q&A session.

Program:

Moderators: Taylor J. Abel, MD and Robert Bollo, MD 

8:30 AM E.01 Anterior Nucleus of the Thalamus DBS Versus Best Medical Therapy Including VNS for Pharmaco-Resistant Epilepsy: Results of the FRANCE STUDY, a Randomized, Multisite, Open Label Trial | Stephan Chabardes, MD, PhD 

8:45 AM E.02 Laser Interstitial Thermal Therapy for Mesial Temporal Lobe Epilepsy: Multicenter Study in 268 Consecutively Treated Patients Including Outcomes of Subsequent Temporal Lobectomy for Seizure Recurrence | Brett E. Youngerman, MD, MS 

9:00 AM E.03 Ablation of Apparent Diffusion Coefficient Hyperintensity Clusters in the Hippocampus During MR-Guided Laser Interstitial Thermal Therapy Improves Seizure Outcome in Mesial Temporal Lobe Epilepsy | Min Jae Kim, BSc 

9:15 AM  E.04 Predicting Surgical Outcome in Temporal Lobe Epilepsy Utilizing Non-invasive Markers with Functional Imaging and Scalp EEG | Layton Lamsam, MD 

9:30 AM  E.05 Higher Brain Extracellular Glutamine Levels Correlate with Seizure-Free Outcome in Patients with Drug-Resistant Epilepsy | Isaac Boateng, MHS 

9:45 AM  E.06 White Matter Resection Associated With Language Decline After Anterior Temporal Lobe Resection | Lawrence P. Binding, BSc, MSc 

10:00 AM  E.07 Changes in the Functional Brain Network of Children Under-going Repeated Epilepsy Surgery: an EEG source connectivity study | Eleanora Tamilia, PhD 

10:15 AM  E.08 Comparison of Standard and Closed-Loop Vagus Nerve Stimulation for Treatment of Pediatric Drug-Resistant Epilepsy: A Propensity-Matched Retrospective Cohort Study | Nallammai Muthiah, MS 

Activity Type
Platform Session
Credit
Non-CME
Format
In person
Career Stage
Early Career (typically 0-5 years from completion of training)
Mid-Career (typically 6-15 years from completion of training)
Senior (typically >15 years from completion of training)
Audience
Clinicians
Scientists/Researchers
Advanced Practice Providers
Fellows/Trainees
Pharmacists
Behavioral Health Providers
Nurses
Technicians
Advocates
Demographic
Clinical
Research
First-time Attendees
Young Professionals